Vector boson pair production in e-e- collisions with polarized beams

The $W$-boson pair production in $e^-e^-$ collisions with polarized beams is investigated. The helicity amplitudes are derived for general couplings and the conditions for a good high-energy behaviour of the cross-section are given. The results are applied to the heavy vector boson production in the context of the left-right symmetric model. The Ward identities and the equivalence theorem are also discussed.Comment: 17 pages+ 8 figures(uuencoded compressed ps-file appended), HU-SEFT R 1994-09 (the original version of the file was unreproducable in some computers

Linear Collider Test of a Neutrinoless Double Beta Decay Mechanism in left-right Symmetric Theories

There are various diagrams leading to neutrinoless double beta decay in left-right symmetric theories based on the gauge group SU(2)_L x SU(2)_R. All can in principle be tested at a linear collider running in electron-electron mode. We argue that the so-called lambda-diagram is the most promising one. Taking the current limit on this diagram from double beta decay experiments, we evaluate the relevant cross section e e to W_L W_R, where W_L is the Standard Model W-boson and W_R the one from SU(2)_R. It is observable if the life-time of double beta decay and the mass of the W_R are close to current limits. Beam polarization effects and the high-energy behaviour of the cross section are also analyzed.Comment: 17 pages, 6 figures. v2: minor changes, references added, to be published in EPJ

Production of qqQQ final states in ee collisions in the left-right symmetric model

We consider the reaction ee ->qqQQ as a test of lepton number non-conservation in the framework of the left-right-symmetric electroweak model. The main contributions to this process are due to Majorana neutrino exchange in t-channel and doubly charged Higgs (Delta{--}) exchange in s-channel with a pair of right-handed weak bosons (WR) as intermediate state. We show that in a linear ee collider with the collision energy of 1 TeV (1.5 TeV) the cross section of this process is 0.01 fb (1 fb), and it will, for the anticipated luminosity of 10**{35} cm**{-2}, be detectable below the WR threshold. We study the sensitivity of the reaction on the masses of the heavy neutrino, WR and Delta{--}.Comment: 24 pages, 9 eps figures, uses axodraw.st

INVERSE NEUTRINOLESS DOUBLE-BETA DECAY IN GAUGE THEORIES WITH CP VIOLATION

We investigate the reactions $e^-e^- \rightarrow W_i^-W_j^-$ for various gauge bosons production processes in the frame of the standard model with additional right-handed neutrinos and the Left-Right symmetric model. The present bounds on the various model parameters are taken into account. The question of the cross section behaviour for large energy and the CP violation problems are discussed.Comment: 21 pages,latex, figures not included (hard copy available on request

Influence of the left-handed part of the neutrino mass matrix on the lepton number violating e-e- -> W-W- process

Influence of the neutrino mass submatrix $M_L$ on the e-e- -> W-W- process is discussed. Taking into account various possible CP signatures of heavy neutrinos it is shown that, in some cases, nonzero $M_L$ substantially changes predictions for maximum possible values of the e-e- -> W-W- cross section. A direct role of the $\omega^2$ parameter (coming from neutrinoless double beta decay) is clarified. The consequences of doubly charged Higgs particles $\delta^{--}$ with resonances even far away from energies of the future linear lepton collider ($\sqrt{s}=0.5-1$ TeV) are studied.Comment: revtex, epsfig, 5 figures, 9 pages. To appear in Phys.Rev.

Cancer-related fatigue: clinical practice versus practice guidelines

Purpose This study investigated adherence to treatment guidelines on cancer-related anaemia and fatigue (CRA/CRF) and factors influencing the choice of intervention. Methods In this prospective, observational study, 136 cancer patients being treated with chemotherapy in a large community hospital completed a questionnaire at consecutive outpatient visits assessing fatigue (the Functional Assessment of Chronic Illness Therapy—Fatigue) and fatigue-related counselling and advice received. Data on administration of chemotherapy and use of epoetin or blood transfusions were abstracted from the medical records. Results Fifty-three percent of patients with severe anaemia (Hb<10 g/dl) and 6% of patients with less severe anaemia (Hb levels 10-12 g/dl) received treatment (epoetin and/or blood transfusions). Half of the patients with less severe anaemia reported clinically relevant levels of fatigue. More than 50% of all patients received fatigue-related counselling, primarily at the start of chemotherapy. Most counselling was directed at energy conservation. Fatigue was not associated significantly with the use of epoetin or blood transfusion. Patients receiving palliative treatment (17%), male patients (16%) and patients with a low Hb level (<6.2 g/dl, 38%) were treated significantly more often with epoetin. Conclusions In daily clinical practice, guidelines concerning the use of epoetin or blood transfusion in severe CRA are adhered to in about half of the cases. In patients with less severe anaemia, the level of fatigue did not play a significant role in the use of epoetin. According to current guidelines, counselling on CRF should be directed primarily at activity enhancement. However, only a minority of patients receive such counselling

A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study

The aim of this study was to evaluate the long-term outcome in 61 patients with medication-overuse headache (MOH) who 4 years previously had been included in a randomized open-label prospective multicentre study. Sixty patients still alive after 4 years were invited to a follow-up investigation. Fifty patients (83%) participated. Sixteen visited a neurologist, 22 were interviewed through telephone, 2 gave response by a letter, and 10 were evaluated through hospital records. The influence of baseline characteristics on outcome 4 years later was evaluated by non-parametric tests. p values below 0.01 were considered significant. At follow-up, the 50 persons had a mean reduction of 6.5 headache days/month (p < 0.001) and 9.5 acute headache medication days/month (p < 0.001) compared to baseline. Headache index/month was reduced from 449 to 321 (p < 0.001). Sixteen persons (32%) were considered as responders due to a ≥50% reduction in headache frequency from baseline, whereas 17 (34%) persons met the criteria for MOH. None of the baseline characteristics consistently influenced all five outcome measures. Total Hospital Anxiety and Depression Scale (HADS) score at baseline was predictors (p < 0.005) for being a responder after 4 years. At 4 years’ follow-up, one-third of the 50 MOH patients had ≥50% reduction in headache frequency from baseline. A low total HADS score at baseline was associated with the most favorable outcome

Signatures of Right-Handed Majorana neutrinos and gauge bosons in eγe \gamma Collisions

The process $e^- \gamma \to e^+ W_R^- W_R^-$ is studied in the framework of the Left-Right symmetric model. It is shown that this reaction and $e^- \gamma \to l^+ W_R^- W_R^-$ for the arbitrary final lepton are likely to be discovered for CLIC collider option. For relatively light doubly charged Higgs boson its mass does not have much influence on the discovery potential, while for heavier values the probability of the reaction increases.Comment: 18 pages, 7 figures, LaTe

Headache and migraine during pregnancy and puerperium: the MIGRA-study

There is little prospectively gathered data on the course of headaches during pregnancy and postpartum, and the influence of breastfeeding is unclear. This is a large, prospective study, which invited all pregnant women in the catchment area during a defined period. All participants (n = 2,126) filled in questionnaires concerning headache. Among these, a total of 208 women with migraine according to the International Headache Society criteria also filled in detailed headache diaries during pregnancy and the puerperal period. Freedom from earlier headaches during pregnancy was significantly more common than new onset of headache during pregnancy (p < 0.001). This was not influenced by prior use of oral contraceptives. According to the diaries, there was a gradual decrease during pregnancy in the frequency of all headaches and of self-considered migraine. There was also a significant decrease in the duration of headaches (p < 0.001) during pregnancy compared to before. Earlier parity did not influence the course. Apart from a significant increase during the first week postpartum (p < 0.01), the overall occurrence of headaches during puerperium did not differ from the pregnancy period. Compared to pregnancy, there was a postpartum increase in the mean intensity (p < 0.01) and duration (p = 0.050) of headaches, as well as in the mean number of analgesics used (p < 0.001). Breastfeeding did not influence the occurrence of headaches postpartum. These data are of practical value for informing pregnant migraineurs about the typical clinical prospects and for giving advice on breastfeeding

Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study)

This paper was presented in part at the II Congreso Colombiano de Atención Farmacéutica, Medellín, Colombia, September 27, 2013.Background: Epilepsy is a complex chronic disorder which affects health-related quality of life (HRQOL), especially in women. Pharmaceutical care (PC) allows direct intervention between the pharmacist, the patient and the other healthcare team members to optimise treatments in order to reduce negative outcomes related to medication and contribute to improving HRQOL. The aim of the study was to establish the impact of the application of a pharmaceutical care programme on the HRQOL of women with epilepsy.Methods: This study is a pragmatic randomised controlled trial involving women with epilepsy (WWE) over 18 years of age. The intervention group (IG) received a pharmaceutical care programme consisting of medication review follow-up according to Dáder’s method, health education and therapeutic drug monitoring of anticonvulsants. The impact was assessed by changes in seizure frequency, in the self-administered questionnaires (the QOLIE-31, Liverpool AEP, CES-D, Haynes-Sackett test and Moriski-Green test) and between the first interview and the one at the end of six months of follow-up. A Student’s t-test was performed to compare the final QOLIE-31 score between groups and a paired Student’s t-test was used to determine the change in each group between the start and the end of follow-up.Results: One hundred eighty-two WWE entered the study and 144 (79.1%) completed it. The t-test for comparing the final QOLIE-31 scores between groups yielded a t = −2.166 and confidence interval (CI) (95%): −10.125; −0.4625, p-value =0.0319. The change (Δ) in the QOLIE-31 score for the IG was 12.45 points (p-value <0.001) and for the control group it was 2.61 (p-value =0.072). With 10.7 as the minimally important change we found a relative risk of 2.17 (CI: 1.37; 3.43) and a number needed to treat (NNT) of 3.5.Conclusions: The study demonstrated that the application of a pharmaceutical care programme significantly improves HRQOL in WWE. The NNT we found allows a recommendation to implement the PC programme for the additional benefit that would be obtained in patients’ HRQOL.This study was funded by a competitive investigator grant award from the Universidad Nacional de Colombia (Colombia) - Research Division of Bogotá (ref: 202010011419 Quipu Code)